Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GTPase, IMAP family member 3 pseudogene (GIMAP3P) is classified as a pseudogene in humans, meaning it resembles a functional gene but does not encode a functional protein product. It is part of the IMAP (immunity-associated nucleotide) GTPase gene family, which is generally involved in immune cell survival and function, but this specific pseudogene (GIMAP3P) is not believed to have a biological function and does not act as a drug target or therapeutic receptor. Its gene locus is on chromosome 7q36.1. This is a pseudogene rather than an active protein-coding gene. Pseudogenes are typically not considered therapeutic targets because they do not encode active proteins or functional receptors. There is no evidence for a role in disease, biological function, or drug targeting. Aliases sometimes conflate with closely related protein-coding family members (such as GIMAP3 in mouse), but the human GIMAP3P refers specifically to a noncoding pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GTPase, IMAP family member 3 pseudogene (GIMAP3P).